Fani M - Search Results

1

Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging.

Antwi K, Hepprich M, Müller NA, Reubi JC, Fani M, Rottenburger C, Nicolas G, Kaul F, Christ ER, Wild D. Antwi K, et al. Among authors: fani m. Clin Nucl Med. 2020 Sep;45(9):e386-e392. doi: 10.1097/RLU.0000000000003124. Clin Nucl Med. 2020. PMID: 32558709 Free article. Clinical Trial.

2

Development of new folate-based PET radiotracers: preclinical evaluation of ⁶⁸Ga-DOTA-folate conjugates.

Fani M, Wang X, Nicolas G, Medina C, Raynal I, Port M, Maecke HR. Fani M, et al. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):108-19. doi: 10.1007/s00259-010-1597-8. Epub 2010 Aug 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 20799032

3

Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.

Fani M, Mueller A, Tamma ML, Nicolas G, Rink HR, Cescato R, Reubi JC, Maecke HR. Fani M, et al. J Nucl Med. 2010 Nov;51(11):1771-9. doi: 10.2967/jnumed.110.076695. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956465 Free article.

4

PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.

Fani M, Del Pozzo L, Abiraj K, Mansi R, Tamma ML, Cescato R, Waser B, Weber WA, Reubi JC, Maecke HR. Fani M, et al. J Nucl Med. 2011 Jul;52(7):1110-8. doi: 10.2967/jnumed.111.087999. Epub 2011 Jun 16. J Nucl Med. 2011. PMID: 21680701 Free article.

5

First clinical evidence that imaging with somatostatin receptor antagonists is feasible.

Wild D, Fani M, Behe M, Brink I, Rivier JE, Reubi JC, Maecke HR, Weber WA. Wild D, et al. Among authors: fani m. J Nucl Med. 2011 Sep;52(9):1412-7. doi: 10.2967/jnumed.111.088922. Epub 2011 Aug 18. J Nucl Med. 2011. PMID: 21852357 Free article.

6

Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro.

Cescato R, Waser B, Fani M, Reubi JC. Cescato R, et al. Among authors: fani m. J Nucl Med. 2011 Dec;52(12):1886-90. doi: 10.2967/jnumed.111.095778. Epub 2011 Nov 8. J Nucl Med. 2011. PMID: 22068898 Free article.

7

Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.

Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR. Abiraj K, et al. Among authors: fani m. J Nucl Med. 2011 Dec;52(12):1970-8. doi: 10.2967/jnumed.111.094375. Epub 2011 Nov 11. J Nucl Med. 2011. PMID: 22080443 Free article.

8

In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.

Fani M, Tamma ML, Nicolas GP, Lasri E, Medina C, Raynal I, Port M, Weber WA, Maecke HR. Fani M, et al. Mol Pharm. 2012 May 7;9(5):1136-45. doi: 10.1021/mp200418f. Epub 2012 Apr 23. Mol Pharm. 2012. PMID: 22497506

9

Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications.

Fani M, Braun F, Waser B, Beetschen K, Cescato R, Erchegyi J, Rivier JE, Weber WA, Maecke HR, Reubi JC. Fani M, et al. J Nucl Med. 2012 Sep;53(9):1481-9. doi: 10.2967/jnumed.112.102764. Epub 2012 Jul 31. J Nucl Med. 2012. PMID: 22851637 Free article.

10

Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.

Wang X, Fani M, Schulz S, Rivier J, Reubi JC, Maecke HR. Wang X, et al. Among authors: fani m. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1876-85. doi: 10.1007/s00259-012-2231-8. Epub 2012 Aug 29. Eur J Nucl Med Mol Imaging. 2012. PMID: 22926735 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters